Nazol (Ketoconazole)

Quick links

Choose a section

Quick links to important sections

Advertisements

Nazol (Ketoconazole)

Advertisements
Advertisements

Overview of Nazol (Ketoconazole)

Quick Facts

Property Description
Active ingredient Ketoconazole (INN)
Form Tablets, Cream, Shampoo
Pharmacological class Antifungal agent (Antimycotic)
Common purpose Control of fungal proliferation
Origin Synthetic compound (Azole derivative)

What Type of Medicine is Nazol (Ketoconazole)?

Nazol is a pharmaceutical preparation that utilizes the active ingredient Ketoconazole, a synthetic compound classified as a potent antifungal agent (antimycotic). This drug belongs to the pharmacological class of azoles, specifically identified as an imidazole derivative. This classification is clinically recognized for its established mechanism against fungal pathogens. This designation signifies that the preparation is specifically designed to manage and control infections caused by various fungal organisms. As an azole derivative, Ketoconazole has a chemical structure that enables it to address a broad-spectrum of fungi, including yeasts and dermatophytes. Azole antifungal agents are used across a range of fungal infections.


Composition, Origin, and Available Forms

The preparation is formulated as a single-ingredient product featuring Ketoconazole, which determines its primary action and is available in multiple dosage form(s) suitable for different routes of exposure. The drug is administered via two primary route(s) of administration: topical preparations, such as cream or shampoo, and tablets for oral use. The versatility of the Ketoconazole preparation is a distinguishing feature, allowing it to treat both superficial and systemic infections. For instance, the cream is formulated with an emulsifying base, while the oral tablets are composed of excipients that ensure effective systemic delivery, supporting its use in managing conditions where systemic therapy is appropriate.


General Therapeutic Purpose of this Antifungal Agent

The overarching general purpose of Nazol is to assist in controlling conditions caused by fungal proliferation due to its established antifungal agent activity. The efficacy of Ketoconazole stems from its ability to disrupt the vital structure of fungal cells, rendering the organisms nonviable and stopping their spread. This fundamental action allows the preparation to address various mycoses and fungal infections by neutralizing the causative microbial agent. Ketoconazole functions by altering cell membrane permeability in fungi.

Regulatory References

  1. Azole Antifungal Drugs (NIH)
Advertisements

What side effects are possible with Nazol (Ketoconazole)?

Possible Side Effects and Safety Information

The safety profile of Nazol (ketoconazole) is structured around the risk of serious adverse reactions, as documented in official government regulatory information.


Serious and Clinically Significant Risks

Ketoconazole carries a Boxed Warning highlighting the risks of Hepatotoxicity (liver injury) and serious Cardiac Effects.

  • Fatal Hepatotoxicity: Severe liver injury, including cases requiring liver transplantation or resulting in death, has been reported. This risk is present regardless of dose or duration of treatment. Regulatory authorities mandate that patients undergo baseline and frequent (often weekly) monitoring of liver enzyme levels (such as serum ALT) throughout the treatment course.
  • QT Prolongation and Torsades de Pointes: The medicine can cause significant QT prolongation, an electrical abnormality in the heart that may lead to life-threatening ventricular tachyarrhythmias (e.g., torsades de pointes).
  • Adrenal Insufficiency: Treatment can lead to adrenal insufficiency, a condition where the adrenal glands do not produce sufficient hormones.

Safety-Related Restrictions and Contraindications

  • Contraindications: Ketoconazole is contraindicated (must not be used) in patients with acute or chronic liver disease due to the high risk of compounding liver damage. It is also contraindicated with numerous medications (e.g., dofetilide, cisapride, quinidine) because of the high risk of severe drug interactions, primarily leading to dangerous QT prolongation.
  • Restricted Use: The medicine's use is officially restricted to treating specific, serious fungal infections only when alternative treatment options are not available or are not tolerated by the patient.
Advertisements

Overdose and Emergency Response

Overdose with systemic Ketoconazole is associated with the potential for severe and life-threatening toxicity, primarily impacting the hepatic, endocrine, and cardiovascular systems. The officially documented manifestations of overdose include signs of acute liver injury, such as jaundice, unrelenting nausea, vomiting, anorexia, and dark urine. Furthermore, there is a risk of severe adrenal insufficiency and life-threatening ventricular dysrhythmias, including Torsades de pointes. Fatal outcomes linked to severe hepatotoxicity are documented as a potential complication in cases of systemic overdose.

Mandatory Emergency Actions

Symptom/Condition Regulatory-Mandated Action
Collapse, Seizure, or Breathing Trouble Immediately call emergency services (911/equivalent).
Signs of Liver Problems (Jaundice, Dark Urine, Severe Nausea) Seek medical attention right away. Treatment must be stopped immediately.

Regulatory documents state that no specific antidote is known for Ketoconazole overdose; therefore, treatment is symptomatic and supportive. Supportive care may include procedures like gastric lavage or the administration of activated charcoal if performed within one hour of ingestion. Close monitoring of vital signs, blood pressure, fluid and electrolyte balance, and liver function is required following exposure to excessive amounts of the drug.

Advertisements

Therapeutic Uses of Nazol (Ketoconazole)

What Nazol (Ketoconazole) Treats: Main Uses and Benefits

Ketoconazole is commonly used to help manage a range of fungal and yeast infections on the skin and scalp, addressing symptoms associated with fungal activity.

This medication is applied across therapeutic domains involving certain distressing symptoms, including flaking, scaling, intense itching (pruritus), and skin redness. It is relevant for managing conditions such as seborrheic dermatitis, tinea (ringworm, athlete's foot, jock itch), and pityriasis versicolor. When symptoms intensify and supportive relief is needed, this medicine helps to manage the symptomatic discomfort associated with fungal activity. In more specialized contexts, the systemic form may be applied in addressing serious, deep-seated fungal diseases like histoplasmosis when other therapeutic options are unavailable. The use of this medication provides supportive relief that helps patients cope more steadily with symptom fluctuations and supports improved day-to-day comfort.

“This medication is commonly used to address groups of symptoms that may become intense or disruptive due to active fungal overgrowth.”


Quick Fact: Relief for Fungal-Induced Skin Discomfort Symptom Focus Therapeutic Goal
Scaling and Flaking Contributes to easing visible skin manifestations
Intense Pruritus May assist with supporting comfort and functional stability
Systemic Burden Helps ease the overall symptom burden in severe cases

Regulatory References

  1. Ketoconazole Topical: MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Nazol (Ketoconazole) — Official Regulatory Information

This section summarizes the official rules governing the eligibility and non-eligibility for Ketoconazole, primarily for the oral tablet formulation.

Category Official Regulatory Statement
Populations for whom use is allowed (as stated in label) Adults with specific systemic fungal infections who have failed or are intolerant to other effective antifungal therapy [FDA Label].
Populations for whom use is contraindicated Patients with acute or chronic liver disease [FDA Label]. Patients with pre-existing or acquired QTc prolongation [EMA/SmPC]. Patients with known hypersensitivity to ketoconazole or any excipients [FDA Label].
Age-related eligibility rules Pediatric Use: Safety and effectiveness have not been established in children younger than 2 years of age [Mayo Clinic]. Geriatric Use: No specific dose adjustment is mandated; however, greater sensitivity in older individuals cannot be ruled out [FDA Label].
Condition-specific eligibility rules Adrenal function: Patients with adrenal insufficiency or borderline function require monitoring [FDA Label]. Gastric acidity: Absorption is impaired by low stomach acid (e.g., achlorhydria), requiring conditional use with an acidic beverage [DailyMed].

Eligibility Classifications (High-Level)

Category Classification Statement
Eligibility severity classification Contraindicated (Liver Disease, QTc prolongation), Restricted/Conditional Use (Adrenal monitoring, Low Gastric Acidity), Use Not Established (Children under 2 years).
Eligibility-context constraints The oral tablet is not indicated for use as a first-line treatment for any fungal infection [FDA Label].

Resulting Eligibility Structure

  • The oral tablet is contraindicated in patients with acute or chronic liver disease or known hypersensitivity to the drug.
  • Use is restricted to patients with severe systemic fungal infections for whom alternative effective therapy is unavailable or cannot be tolerated.
  • Use in the pediatric population, specifically children under 2 years of age, is officially classified as safety and efficacy not established by regulatory authorities.

Connection to the overall eligibility profile: The official documents define the eligibility for Ketoconazole oral tablets with extreme caution, imposing absolute prohibitions based on hepatic and cardiac risks. This profile mandates a second-line or last-resort status for the oral tablet, meaning that only patients who have failed or cannot tolerate other therapies are officially considered eligible for its use.

Advertisements

What should I know about interactions with other medicines?

Oral Ketoconazole (Nazol) possesses a complex and highly restricted interaction profile, primarily defined by its regulatory classification as a potent inhibitor of the CYP3A4 enzyme system. This metabolic inhibition significantly increases the plasma concentrations of many co-administered medicines that are also metabolized by this enzyme, necessitating several prohibitions and constraints.

Classification Examples of Interacting Substances
Contraindicated Combinations Dofetilide, Quinidine, Simvastatin, Lovastatin, Oral Midazolam, Ergot Alkaloids (e.g., Ergotamine)
Exposure-Altering Agents Ritonavir (increases Ketoconazole levels), Rifampin (reduces Ketoconazole levels)

Co-administration is contraindicated with agents that pose a severe risk of QT interval prolongation (antiarrhythmics) or skeletal muscle toxicity (statins). Use with alcohol is explicitly advised against due to a documented increased risk of liver damage and the potential for a disulfiram-like reaction. Furthermore, Ketoconazole tablets require gastric acidity for dissolution; therefore, administration of Acid-Reducing Agents (like antacids or H₂-blockers) must be separated by at least two hours to prevent significantly reduced absorption. The official regulatory profile also states that use is contraindicated in patients with Acute or Chronic Liver Disease.

Advertisements

Mechanism of Action

Fungal Cell Membrane Structural Disruption

Ketoconazole's primary action involves enzyme-mediated interference with fungal sterol metabolism. The molecule acts as a non-competitive inhibitor of Lanosterol 14alpha-demethylase ( CYP51), a cytochrome P450 enzyme involved in fungal sterol synthesis . By binding to the heme iron of CYP51, the drug blocks the conversion of lanosterol into ergosterol, a fundamental sterol for fungal cell membranes. This mechanistic cascade leads to the accumulation of toxic sterol precursors within the fungal cell, resulting in altered membrane chemical composition, compromise of fungal cell viability, and increased cellular permeability.

Modulation of Mammalian Steroid Hormone Synthesis

This secondary domain covers the drug's influence on human physiological pathways. Ketoconazole also inhibits several mammalian Cytochrome P450 enzymes (like CYP17 A1) involved in the body's steroidogenesis pathway . This action reduces the enzymatic conversion of steroid precursors into hormones, including cortisol and androgens. This mechanism produces a reduction in circulating androgen and cortisol levels, which reflects the drug's broader enzymatic influence on the endocrine system.

Advertisements

Dosage and Administration Information

How to use Nazol (Ketoconazole) Topical Formulations

Nazol, containing the antifungal agent Ketoconazole, is available in topical forms such as creams and shampoos to treat various fungal skin conditions. You must always use this medication exactly as prescribed by your healthcare provider or as directed on the product label. Do not use it more often or for a longer duration than recommended, as this will not speed up the recovery and may increase the risk of side effects.


Using Ketoconazole Cream

  1. Preparation: Cleanse and thoroughly dry the affected skin area before application.
  2. Application: Gently apply a small amount of the cream to cover the affected skin and a small surrounding area, usually once or twice daily. Wash your hands thoroughly immediately after application.
  3. Duration: Continue using the cream for the full treatment course, even if symptoms improve, to ensure the infection is completely cleared. Stopping prematurely may lead to recurrence.

Using Ketoconazole Shampoo

  1. Preparation: Wet your hair and scalp (or the affected skin area, such as the chest or back) thoroughly with water.
  2. Application: Apply the prescribed amount of shampoo to the affected area, work into a lather, and gently massage into the skin.
  3. Contact Time: Allow the shampoo to remain on the skin or scalp for 3 to 5 minutes to ensure sufficient contact time for the medication to work.
  4. Rinsing: Rinse the area well with water and dry gently. For dandruff or seborrheic dermatitis, the shampoo is typically used twice a week for 2 to 4 weeks, followed by maintenance use.

Important Safety Precautions

  • External Use Only: Ketoconazole topical products are for skin use only. Avoid contact with your eyes, nose, mouth, or vagina. If contact occurs, rinse thoroughly with water.
  • Missed Dose: If you miss a dose, apply it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose.
  • Monitoring: If your condition does not improve or worsens after the full prescribed course of treatment, consult your healthcare provider.
Advertisements

Recent Clinical Evidence

Recent Clinical Evidence: Ketoconazole

Ketoconazole is an azole antifungal agent initially used in oral and topical formulations. Clinical evidence for the oral formulation has shifted significantly due to safety concerns, leading to its current use being limited primarily to serious systemic fungal infections when other treatments are unavailable, or for specific off-label applications such as Cushing's syndrome and prostate cancer due to its observed effect on human steroid synthesis enzymes.

Topical Formulations

Research continues to support the use of topical ketoconazole for superficial fungal and yeast infections. A significant volume of evidence demonstrates clinical effectiveness for Malassezia-related skin conditions, including seborrheic dermatitis (SD) and pityriasis versicolor (PV). One Phase III trial, for instance, showed a significantly greater percentage of subjects with moderate to severe SD achieved successful treatment outcomes with a 2% ketoconazole gel compared with a vehicle gel.

Safety and Pharmacokinetics

Systemic absorption of topical ketoconazole is typically minimal in healthy adults. However, studies in infants with extensive application have detected plasma levels, highlighting the need for caution in this group. The main concern with the oral formulation remains its potential for hepatotoxicity (liver damage), which has been a major focus of regulatory review globally. Due to this risk, liver function monitoring is frequently recommended when the oral agent is used.

Use in Specific Groups and Off-Label Studies

Limited clinical data and animal studies have explored the potential for ketoconazole shampoo to mitigate some types of hair loss. This application is considered off-label and not fully conclusive, though some research suggests it may lead to similar improvements in hair density as certain standard treatments. Further studies are required to confirm its long-term benefit and mechanism in this context.

Key Studies & References

  1. Ketoconazole for the Treatment of Docetaxel-Naïve Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Systematic Review
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Nazol (Ketoconazole) (FAQ)


Q: What are the main differences between Nazol cream, shampoo, and oral tablets?

A: The official product information describes Nazol's various forms based on their purpose. The cream and shampoo are topical preparations designed for localized treatment of superficial fungal conditions on the skin and scalp. The oral tablet is for systemic use (internal treatment), but due to associated safety risks, its use is severely restricted by regulatory authorities.

Q: Is the 1% strength of Nazol available over-the-counter in most places?

A: Regulatory documents indicate that the 1% concentration of ketoconazole shampoo has been approved for Over-the-Counter (OTC) use in the United States. This indicates it has been approved for non-prescription purchase for the control of common dandruff.

Q: What conditions is Nazol typically prescribed for?

A: Topical Nazol is prescribed for superficial conditions like tinea infections (such as ringworm or athlete's foot), cutaneous candidiasis, and seborrheic dermatitis. In contrast, official labels restrict the oral tablet to treating specific, serious systemic fungal infections only when alternative therapies are unavailable or cannot be tolerated by the patient.

Q: What are the most common expected side effects of topical Nazol products?

A: In clinical trials for topical Nazol formulations, the most common reported effects (occurring in over 1% of patients) included application site burning and a general application site reaction. These effects relate to the area where the product is applied.

Q: What are the signs of a severe or serious adverse reaction to Nazol?

A: Official warnings advise watching for signs of severe liver injury, such as severe, unexplained fatigue, yellowing of the skin or eyes (jaundice), dark urine, pale stools, or abdominal pain. These symptoms are considered medical emergencies and require prompt contact with a healthcare provider.

Q: Is Nazol cream or shampoo considered a steroid medication?

A: No. According to the drug's classification, Nazol (Ketoconazole) is a synthetic compound categorized as a potent antifungal agent (an azole derivative). It does not belong to the pharmacological class of steroids.

Q: How long does it typically take to see an improvement in symptoms when using Nazol?

A: Official guidance indicates that improvement time varies by the condition being treated. For common issues like seborrheic dermatitis, jock itch, or dandruff, improvement is usually observed within 2 to 4 weeks. Certain infections, such as pityriasis versicolor treated with the shampoo, may show improvement as quickly as five days.

Q: What should a patient expect if their fungal infection returns after stopping Nazol treatment?

A: For conditions that are known to recur, such as dandruff or seborrheic dermatitis, regulatory guidance indicates the shampoo can sometimes be used again on a maintenance schedule to help control the condition. For other types of infections, it is common to seek reevaluation from a healthcare provider.

Q: Can Nazol be used by women who are pregnant or are breastfeeding?

A: Topical forms of Nazol (cream and shampoo) are generally considered acceptable during pregnancy and breastfeeding because only tiny amounts are absorbed into the bloodstream. However, official information advises that any use should occur only when the potential benefit to the patient justifies the potential risk.

Q: Can Nazol topical products be used at the same time as other creams or lotions?

A: Official guidance states that topical Nazol can be used with most other skin treatments. If a mild steroid cream is also being used, official guidance suggests that application should be separated by time, such as applying them at different times of the day.

Q: What is the key difference between prescription 2% Nazol and its 1% over-the-counter alternatives?

A: The primary difference is the concentration of the active ingredient and the regulatory status. The 1% concentration is approved for Over-the-Counter (OTC) use for dandruff control, while the higher 2% concentration typically requires a doctor's prescription for a wider range of indications.

Q: What non-drug personal care products are generally safe to use alongside Nazol shampoo?

A: While there is no specific regulatory list of compatible products, the official label does caution that ketoconazole shampoo can potentially cause changes in hair texture or color. It may also result in the temporary removal of the curl from permanently waved hair.

Q: Is Nazol effective for skin issues that are caused by bacteria or viruses?

A: Nazol is classified and indicated solely as an antifungal agent (antimycotic). Its mechanism of action is specific to fungal pathogens, and official documentation indicates it is not intended for the treatment of conditions caused by bacteria or viruses.

Q: Are there any known interactions between Nazol and common over-the-counter pain relievers?

A: Official drug interaction information suggests caution when taking oral Nazol alongside other medications that are potentially toxic to the liver, such as high-dose Acetaminophen (paracetamol). The combination may increase the risk of liver injury.

Q: Does sun exposure or tanning affect skin areas that have been treated with Nazol?

A: Regulatory information for certain topical forms of Nazol, such as the foam, advises that use may result in photoallergenicity. Patients should be advised to avoid sun exposure or use clothing to cover the treated areas when using these formulations.

Q: How long does Nazol stay in the body after the last dose is taken?

A: Pharmacokinetic studies indicate that the elimination half-life of oral ketoconazole is highly variable among individuals. For typical oral doses, the mean half-life is reported in official documents to be between 3 to 10 hours.

Q: What are the typical side effects specific to using Nazol shampoo on the scalp?

A: Reported effects from the official label include hair discoloration, abnormal hair texture, removal of the curl from permed hair, itching, dry skin, and a skin burning sensation.

Q: Does Nazol affect hormonal birth control or other forms of contraception?

A: Due to its mechanism, oral Nazol can potentially increase the blood concentrations of hormonal contraceptives (such as estrogens and progestins), which may require monitoring by a healthcare provider. The systemic absorption from the topical forms is considered minimal.

Q: Is it common to experience skin irritation or redness after applying Nazol cream?

A: Yes, common side effects reported in clinical trials for the topical cream include application site reaction, which frequently includes irritation, dryness, and erythema (redness). This is generally a localized reaction where the product is applied.

Q: Are there certain foods or drinks, like alcohol, that should be avoided while using Nazol?

A: Official warnings strictly advise that alcohol should be avoided entirely when taking Nazol oral tablets, due to a documented increased risk of liver damage and the potential for a severe disulfiram-like reaction. Grapefruit juice should also be avoided, as it can potentially increase the drug’s blood levels.

Q: Is there a scientific explanation for why some people believe Nazol shampoo helps with hair shedding?

A: The official label notes that limited studies have explored this off-label use, which is theorized to be related to its anti-fungal and anti-inflammatory properties. However, regulatory documents state that the long-term benefit and exact mechanism for this specific use are not fully conclusive or established.

Q: Does Nazol work in the same way for dandruff, seborrheic dermatitis, and other skin fungi?

A: Yes, the fundamental antifungal action of Nazol is the same across all susceptible infections. It works by disrupting the cell membrane of the fungal or yeast organism (such as Malassezia), which is the underlying cause of conditions like dandruff and seborrheic dermatitis.

Q: Are there different approved uses for the Nazol shampoo versus the Nazol cream?

A: Yes, regulatory documentation indicates differences in approved uses. For example, the shampoo is indicated for conditions of the scalp and trunk, such as tinea versicolor and dandruff, while the cream is indicated for various tinea infections and cutaneous candidiasis (a yeast infection).

Q: Can using Nazol topical products for a long period of time lead to any safety concerns?

A: Official safety profiles indicate that systemic absorption from topical use is minimal in healthy adults. However, use for a duration longer than officially recommended is discouraged as it does not speed recovery and may increase the risk of local side effects on the skin.

Q: Why do some sources claim Nazol has a potential effect as a 'DHT blocker'?

A: This claim relates to the drug's known ability to inhibit certain mammalian enzymes involved in the body’s steroidogenesis pathway, which reduces the production of hormones like androgens. This is the basis for the off-label claim, but it is not an approved or indicated effect for the product.

Q: Can Nazol cream be applied to large areas of the skin safely?

A: The official label advises against excessive use. While systemic absorption is minimal, studies involving infants with extensive application of topical products have detected low plasma levels. This suggests that applying to very large areas should be approached with caution.

Q: Is it safe to use Nazol if the product has passed its expiration date?

A: Regulatory guidance requires that unused or expired pharmaceutical products be discarded in accordance with local guidelines. This is because the medication's safety, stability, and guaranteed potency cannot be confirmed or ensured after its printed expiration date.

Q: Can Nazol be used to treat fungal infections on the face, such as beard dandruff?

A: Topical Nazol products are indicated for use on the 'affected skin area,' which may include the face or beard area. When applying to the face, it is important to apply gently and strictly avoid sensitive areas like the eyes, as use may cause localized irritation.

Advertisements

How should Nazol (Ketoconazole) be stored and disposed of?

How to Store and Dispose of Ketoconazole

Official regulatory guidelines strictly define the storage and disposal of ketoconazole to ensure product stability and safety, with requirements varying by dosage form.

Storage Conditions

Ketoconazole preparations must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The tablets must be protected from moisture and dispensed in a tight, light-resistant container. The shampoo requires protection from light.

Handling and Safety

Foam containers are flammable and under pressure, requiring specific handling: they must not be exposed to heat, stored above 49 C (120 F), or punctured/incinerated. All forms of the medication must be stored out of reach of children.

Disposal

Unused or expired ketoconazole product must be discarded in accordance with local, state, and federal requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nazol (Ketoconazole) found in:

A-Z Index: